Results 81 to 90 of about 696,855 (303)
Chinese and western medicine treatment of myocardial fibrosis drugs
Myocardial fibrosis (MF) is a common pathological manifestation of many cardiovascular diseases, such as myocardial infarction, myocardial ischemia, and sudden cardiac death.
Yuxi Zhu +7 more
doaj +1 more source
Myocardial fibrosis during atrial fibrillation: histological and cardiographic predictors
Background. The formation of myocardial fibrosis is the leading mechanism for occurrence of atrial fibrillation (AF). In this regard, an attempt to prevent development of myocardial fibrosis and its treatment is pathogenetically expedient.
R.F. Rakhmatullov +2 more
doaj +1 more source
How do adults with cystic fibrosis cope following a diagnosis of diabetes? [PDF]
The official published version of the article can be obtained from the link below.Aim. This paper is a report of a study examining the experience of adults with cystic fibrosis in adapting to the diagnosis of diabetes, a second chronic illness ...
Reynolds, F, Collins, S
core +1 more source
Schematic illustration of the Pluronic F127 diacrylate/gelatin methacryloyl/poly(3,4‐ethylenedioxythiophene):poly(styrenesulfonate)/celastrol hydrogel (FGPC) for localized myocardial ischemia–reperfusion injury treatment. FGPC combines sustained celastrol delivery with PEDOT:PSS‐mediated conductive support to attenuate acute oxidative/inflammatory ...
Shixin Wang +10 more
wiley +1 more source
Myocardial fibrosis in hypertrophic cardiomyopathy [PDF]
Hypertrophic cardiomyopathy (HCM) is characterised by myocardial hypertrophy, fibrosis and abnormal vascular pathology and is usually caused by mutations in sarcomeric protein genes.
Patel, Vimal
core +1 more source
Intermittent fasting reshapes the gut microbiota in diabetic cardiomyopathy, restoring Akkermansia muciniphila and the microbiota‐associated metabolite 1‐methyl‐L‐histidine. This shift is linked to improved cardiac lipid homeostasis, reduced lipid peroxidation, and attenuated myocardial injury, highlighting a gut microbiota–metabolite–lipid axis in ...
Kaiyuan Jiang +7 more
wiley +1 more source
Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis
Cardiovascular diseases have become the leading cause of death in urban and rural areas. Myocardial fibrosis is a common pathological manifestation at the adaptive and repair stage of cardiovascular diseases, easily predisposing to cardiac death.
Minghui Wang +12 more
doaj +1 more source
Characterization of the Early Cellular Mechanisms Promoting Myocardial Fibrosis
Myocardial fibrosis is a common pathological finding in patients with cardiovascular disease and is believed to be a major contributing factor in the development of end stage organ failure.
Sopel, Mryanda
core
This study revealed that a PEAR1/HIF‐1α/ glycolysis/lactate/H3K18la positive feedback loop in PMVECs that drives the development of S‐ALI. Mechanistically, PEAR1 mediates the binding of HIF‐1α to AARS1, leading to the lactylation of HIF‐1α, the primary lactylation site of which is K172.
Shuai Li +15 more
wiley +1 more source
Background Structural myocardial changes in hypertrophic cardiomyopathy (HCM) are associated with different abnormalities on electrocardiographs (ECGs). The diagnostic value of the ECG voltage criteria used to screen for left ventricular hypertrophy (LVH)
Zsofia Dohy +10 more
doaj +1 more source

